Skip to content

Ultrasonographic study of the effects of the herbal medicine package on the size of fibroma

Ultrasonographic study of the effects of the herbal medicine package on the size of fibroma

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141209020258N147
Enrollment
60
Registered
2020-07-14
Start date
2020-06-04
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids. Maternal care for benign tumor of corpus uteri

Interventions

Intervention 1: Intervention group: One capsule of Iarj Fiqra 500 milligram at the end of the night with warm water and soda soda as a decoction in the morning and night (half an hour before breakfast

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: 15 to 49 years Having a uterine fibroid smaller millimetre No history of uterine cancer in the individual and first-degree relatives No pregnancy No breastfeeding Lack of uterine bleeding, colitis, hemorrhoids, appendicitis, intestinal obstruction, acute inflammatory bowel diseases such as Crohn's disease, ulcerative colitis, abdominal pain of unknown origin, gastric bleeding and esophageal varices Absence of underlying disease

Exclusion criteria

Exclusion criteria: Dissatisfaction

Design outcomes

Primary

MeasureTime frame
Fibroma size. Timepoint: Before and after three months of treatment. Method of measurement: Sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mehdi Salehi

Arak University of Medical Sciences

m.salehi@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026